A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia

Completed · Phase 3 · Has a placebo group

Conditions studied: Insomnia

In brief

The purpose of the study is to evaluate sleep onset following administration of zolpidem tartrate sublingual tablet (Intermezzo) versus placebo in adult insomnia patients.

Key facts

Study ID

NCT00466193

Run by

Transcept Pharmaceuticals

People needed

295

Starts

2007-05-01

Expected to finish

2007-11-01

Last updated by the study team

2012-02-14

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults with history of sleeplessness

You may not qualify if…

• Allergic to investigational drug
• Any conditions and medications that may interfere with study drug evaluation

Where it is running

• Transcept Investigational Site — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.